CorrespondenceResearch LetterPharmacokinetics of Multiple-Dose Levofloxacin in Hemodialysis Patients
Research Letter
Section snippets
Acknowledgements
We thank Ms Keiko Mitome for technical assistance. The corresponding author, Dr Tsuruoka, may be contacted at [email protected].
Support: Drs Tsuruoka and Yamagata are supported by grants from Ministries of Education, Culture, Sports, Science and Technology, and Health, Labor and Welfare of Japan.
Financial Disclosure: The authors declare that they have no relevant financial interests.
References (10)
- et al.
Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma
J Chromatogr B Analyt Technol Biomed Life Sci
(2002) - et al.
Pharmacokinetics of levofloxacin after single and multiple oral doses in patients undergoing intermittent haemodialysis
Int J Antimicrob Agents
(2008) - et al.
Levofloxacin pharmacokinetics in ESRD and removal by the cellulose acetate high performance-210 hemodialyzer
Am J Kidney Dis
(2003) USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States
(2006)- et al.
Evaluation of three methods for the measurement of urea nitrogen in serum as used on six instruments
Am J Clin Pathol
(1980)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.